Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Sharp

Showing results (411-420 of 429) with videos related to

Pageof 43
Sort By:
Annals of the Rheumatic Diseases|May 3, 2007
Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohortVeena K Ranganath, Jeonglim Yoon, Dinesh Khanna, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1980
Neurotransmitter studies of neuroendocrine pathology in depressionB J Carroll, J F Greden, R Haskett, et al.
JSLS : Journal of the Society of Laparoendoscopic Surgeons|January 1, 1997
Functional MR imaging of the porcine kidney: physiologic changes of prolonged pneumoperitoneumE M McDougall, H F Bennett, T G Monk, et al.
The Journal of Rheumatology|January 30, 2010
Equivalent responses to disease-modifying antirheumatic drugs initiated at any time during the first 15 months after symptom onset in patients with seropositive rheumatoid arthritisHaoling H Weng, Veena K Ranganath, Dinesh Khanna, et al.
Acta Psychiatrica Scandinavica|July 6, 2017
NEUROTRANSMITTER STUDIES OF NEUROENDOCRINE PATHOLOGY IN DEPRESSIONBernard J Carroll, John F Greden, Roger Haskett, et al.
The Journal of Rheumatology|July 4, 2008
Automated measurement of joint space width in small joints of patients with rheumatoid arthritisCédric Lukas, John T Sharp, Jane Angwin, et al.
Arthritis and Rheumatism|October 4, 2005
Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trialPhilip J Mease, Dafna D Gladman, Christopher T Ritchlin, et al.
Journal of Environmental Management|December 30, 2025
Rethinking land-use Strategies: A multi-objective analysis of combined sparing and sharing approaches applied across great britainImane El Fartassi, Ryan T Sharp, Victoria A Bell, et al.
Annals of the Rheumatic Diseases|August 8, 2008
Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)P J Mease, P Ory, J T Sharp, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 16, 2000
beta-blocker binding to human 5-HT(1A) receptors in vivo and in vitro: implications for antidepressant therapyE A Rabiner, R N Gunn, M E Castro, et al.
Pageof 43

Showing results (411-420 of 429) with videos related to

Sort By:
Pageof 43
Annals of the Rheumatic Diseases|May 3, 2007
Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohortVeena K Ranganath, Jeonglim Yoon, Dinesh Khanna, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1980
Neurotransmitter studies of neuroendocrine pathology in depressionB J Carroll, J F Greden, R Haskett, et al.
JSLS : Journal of the Society of Laparoendoscopic Surgeons|January 1, 1997
Functional MR imaging of the porcine kidney: physiologic changes of prolonged pneumoperitoneumE M McDougall, H F Bennett, T G Monk, et al.
The Journal of Rheumatology|January 30, 2010
Equivalent responses to disease-modifying antirheumatic drugs initiated at any time during the first 15 months after symptom onset in patients with seropositive rheumatoid arthritisHaoling H Weng, Veena K Ranganath, Dinesh Khanna, et al.
Acta Psychiatrica Scandinavica|July 6, 2017
NEUROTRANSMITTER STUDIES OF NEUROENDOCRINE PATHOLOGY IN DEPRESSIONBernard J Carroll, John F Greden, Roger Haskett, et al.
The Journal of Rheumatology|July 4, 2008
Automated measurement of joint space width in small joints of patients with rheumatoid arthritisCédric Lukas, John T Sharp, Jane Angwin, et al.
Arthritis and Rheumatism|October 4, 2005
Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trialPhilip J Mease, Dafna D Gladman, Christopher T Ritchlin, et al.
Journal of Environmental Management|December 30, 2025
Rethinking land-use Strategies: A multi-objective analysis of combined sparing and sharing approaches applied across great britainImane El Fartassi, Ryan T Sharp, Victoria A Bell, et al.
Annals of the Rheumatic Diseases|August 8, 2008
Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)P J Mease, P Ory, J T Sharp, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 16, 2000
beta-blocker binding to human 5-HT(1A) receptors in vivo and in vitro: implications for antidepressant therapyE A Rabiner, R N Gunn, M E Castro, et al.
Pageof 43